newsfilter
← Latest News
GlobeNewswire·

INVO Fertility Announces a 1:8 Reverse Stock Split Effective Pre-Market Opening on November 28, 2025

  • INVO Fertility, Inc. announced a 1-for-8 reverse stock split effective at 12:01 a.m. Eastern Time on November 28, 2025.
  • The company's common stock will trade on a post-split basis under the same symbol "IVF" on The Nasdaq Capital Market starting November 28, 2025.
  • A new CUSIP number of 44984F807 will be assigned to the common stock following the split.
  • Every 8 shares of issued and outstanding common stock will be exchanged for 1 share, with fractional shares rounded up to the next whole share.
  • Post-split, the company will have approximately 1,891,151 shares of common stock issued & outstanding.
  • Authorized common stock will be proportionately adjusted to 6,250,000 shares after the effective time of the reverse split.
  • INVO Fertility operates a healthcare services business focused on expanding assisted reproductive technology care through INVO Centers & IVF clinics.
  • The company's primary strategy involves operating fertility clinics utilizing its proprietary INVOcell® medical device for intravaginal culture procedures.
  • Current operations include two INVO Centers & one IVF clinic in the United States, alongside the sale & distribution of INVOcell technology to third-party clinics.
  • The release includes forward-looking statements subject to risks & uncertainties that may cause actual results to differ from expectations.